Literature DB >> 10898544

Colon carcinoma with synchronous ovarian metastasis--report and discussion of five cases.

T S Yang1, K C Hsu, R Tang, T C Chang.   

Abstract

Ovarian metastasis may present at the time of initial diagnosis of colon carcinoma or as a later recurrence. Little meaningful information is available regarding the treatment and outcome of synchronous ovarian metastasis of colon carcinoma. This report describes the clinical course of five patients with synchronous ovarian metastasis of colon carcinoma who were treated with aggressive surgery and chemotherapy. The treatment consisted of maximal surgical debulking followed by systemic chemotherapy with weekly 24 h infusion of high-dose 5-fluorouracil and leucovorin. All of the five patients had subsequent disease-free periods ranging from 6 to 43+ months following operation. Two of the patients who had no or minimal peritoneal involvement were still alive without disease at 33 and 43 months. The data from these cases suggest that aggressive surgery and systemic chemotherapy may be highly efficacious in the treatment of colon carcinoma with synchronous ovarian metastasis. Maximal debulking followed by chemotherapy may be particularly effective in those patients with minimal peritoneal involvement.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898544     DOI: 10.1097/00001813-200004000-00009

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  1 in total

1.  A case of metachronous left ovarian metastasis 8 years after surgery for cecal cancer and right ovarian metastasis: Report of a case.

Authors:  Itaru Shigeyoshi; Koji Komori; Takashi Kinoshita; Taihei Oshiro; Seiji Ito; Tetsuya Abe; Yoshiki Senda; Kazunari Misawa; Yuichi Ito; Norihisa Uemura; Seiji Natsume; Jiro Kawakami; Akira Ouchi; Masayuki Tsutsuyama; Takahiro Hosoi; Tomoyuki Akazawa; Daisuke Hayashi; Hideharu Tanaka; Yasushi Yatabe; Yasuhiro Shimizu
Journal:  Nagoya J Med Sci       Date:  2017-02       Impact factor: 1.131

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.